← Back to Search
Loss Of The SdhB, But Not The SdhA, Subunit Of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation And Tumorigenesis
R. Guzy, Bhumika K. Sharma, E. Bell, N. Chandel, P. Schumacker
Published 2007 · Biology, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
ABSTRACT Mitochondrial complex II is a tumor suppressor comprised of four subunits (SdhA, SdhB, SdhC, and SdhD). Mutations in any of these should disrupt complex II enzymatic activity, yet defects in SdhA produce bioenergetic deficiency while defects in SdhB, SdhC, or SdhD induce tumor formation. The mechanisms underlying these differences are not known. We show that the inhibition of distal subunits of complex II, either pharmacologically or via RNA interference of SdhB, increases normoxic reactive oxygen species (ROS) production, increases hypoxia-inducible factor alpha (HIF-α) stabilization in an ROS-dependent manner, and increases growth rates in vitro and in vivo without affecting hypoxia-mediated activation of HIF-α. Proximal pharmacologic inhibition or RNA interference of complex II at SdhA, however, does not increase normoxic ROS production or HIF-α stabilization and results in decreased growth rates in vitro and in vivo. Furthermore, the enhanced growth rates resulting from SdhB suppression are inhibited by the suppression of HIF-1α and/or HIF-2α, indicating that the mechanism of SdhB-induced tumor formation relies upon ROS production and subsequent HIF-α activation. Therefore, differences in ROS production, HIF proliferation, and cell proliferation contribute to the differences in tumor phenotype in cells lacking SdhB as opposed to those lacking SdhA.
This paper references
Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria.
J. Turrens (1985)
Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency
T. Bourgeron (1995)
Mitochondrial reactive oxygen species trigger hypoxia-induced transcription.
N. Chandel (1998)
Generation of Superoxide Anion by Succinate-Cytochromec Reductase from Bovine Heart Mitochondria*
Li Zhang (1998)
A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes
N. Ishii (1998)
Identification and classification of p53-regulated genes.
J. Yu (1999)
Perspectives on Oxygen Sensing
G L Semenza (1999)
Perspectives on oxygen sensing. Cell 98:281–284
G. L. Semenza (1999)
Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1α during Hypoxia
N. Chandel (2000)
Hypoxia-inducible Factor-1α Is a Positive Factor in Solid Tumor Growth
H. Ryan (2000)
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.
B. Baysal (2000)
Progress in understanding structure–function relationships in respiratory chain complex II
B. Ackrell (2000)
Reactive oxygen species generated at mitochondrial complex III stabilize HIF-1-alpha during hypoxia: a mechanism of O2 sensing
N. S. Chandel (2000)
A Defect in the Cytochrome b Large Subunit in Complex II Causes Both Superoxide Anion Overproduction and Abnormal Energy Metabolism in Caenorhabditis elegans *
N. Senoo-Matsuda (2001)
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.
A. Gimenez-Roqueplo (2001)
Activation of the HIF pathway in cancer.
P. Maxwell (2001)
Enhancement of Oxidative Damage to Cultured Cells and Caenorhabditis elegans by Mitochondrial Electron Transport Inhibitors
H. Ishiguro (2001)
Stable suppression of gene expression by RNAi in mammalian cells
P. Paddison (2002)
Inborn errors of complex II--unusual human mitochondrial diseases.
P. Rustin (2002)
Mechanism of Superoxide and Hydrogen Peroxide Formation by Fumarate Reductase, Succinate Dehydrogenase, and Aspartate Oxidase*
K. Messner (2002)
Etiopathogenesis and clinical presentation of carotid body tumors
B. Baysal (2002)
Architecture of Succinate Dehydrogenase and Reactive Oxygen Species Generation
V. Yankovskaya (2003)
The Ubiquinone-binding Site of the Saccharomyces cerevisiae Succinate-Ubiquinone Oxidoreductase Is a Source of Superoxide*
J. Guo (2003)
Direct evidence for expression of type II flavoprotein subunit in human complex II (succinate-ubiquinone reductase).
E. Tomitsuka (2003)
SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology
PB Douwes Dekker (2003)
3‐Nitropropionic Acid Inhibition of Succinate Dehydrogenase (Complex II) Activity in Cultured Chinese Hamster Ovary Cells
A. Scallet (2003)
Function and structure of complex II of the respiratory chain.
G. Cecchini (2003)
Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect
K. Astrom (2003)
Oxygen sensing by HIF hydroxylases
C. Schofield (2004)
The Mitochondrial SDHD Gene Is Required for Early Embryogenesis, and Its Partial Deficiency Results in Persistent Carotid Body Glomus Cell Activation with Full Responsiveness to Hypoxia
J. I. Piruat (2004)
Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators*
C. Dooley (2004)
Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma.
S. McWhinney (2004)
Investigating Mitochondrial Redox Potential with Redox-sensitive Green Fluorescent Protein Indicators*
George T. Hanson (2004)
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
P. Pollard (2005)
A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF‐1α
A. Sanjuán-Pla (2005)
Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation.
K. Mansfield (2005)
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer.
S. Lee (2005)
Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions.
Jean-Jacques Brière (2005)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.
J. Isaacs (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
M. Selak (2005)
Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing.
Robert D Guzy (2005)
A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
P. Dahia (2005)
Crystal Structure of Mitochondrial Respiratory Membrane Protein Complex II
F. Sun (2005)
In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo
K. Yao (2005)
Inhibition of hypoxia inducible factor-1α (HIF-1α) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas
R. Jensen (2005)
Over expression of hypoxia-inducible factor-1alpha in renal and bladder cancer cells increases tumorigenic potency.
Y. Kondo (2005)
A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis.
Takamasa Ishii (2005)
Accumulation of Krebs cycle intermediates and over-expression of HIF1 in tumours which result from germline
P. J. Pollard (2005)
Sequence variation in human succinate dehydrogenase genes: evidence for long-term balancing selection on SDHA
B. Baysal (2006)
Knockdown of hypoxia-inducible factor-1alpha in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate.
Jing Li (2006)
Effect of Antisense Hypoxia-inducible Factor 1&agr; on Progression, Metastasis, and Chemosensitivity of Pancreatic Cancer
Qing Chang (2006)
Nonezymatic formation of succinate in mitochondria under oxidative stress.
N. Fedotcheva (2006)
Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.
D. Dang (2006)
Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells.
M. Selak (2006)
Nonenzymatic formation of succinate in mitochondria under oxidative stress
N. I. Fedotcheva (2006)
Knockdown of hypoxia-inducible factor-1 in breast carcinoma
J. Li (2006)
Nonenzymatic formation of succinate in mitochondria under oxidative stress. Free Radic
N I Fedotcheva (2006)
Knockdown of hypoxia-inducible factor-1␣ in breast carcinoma 730 GUZY ET AL
J Li (2006)
HIF-dependent antitumorigenic effect of antioxidants in vivo.
P. Gao (2007)
The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production
E. Bell (2007)
Ubiquinone-binding Site Mutations in the Saccharomyces cerevisiae Succinate Dehydrogenase Generate Superoxide and Lead to the Accumulation of Succinate*
S. Szeto (2007)
This paper is referenced by
From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy
Emanuela Di Gregorio (2021)
Mitochondrial Metabolism in Carcinogenesis and Cancer Therapy
H. Moindjie (2021)
Succinate Dehydrogenase (SDH)-subunit C regulates muscle oxygen consumption and fatigability in an animal model of pulmonary emphysema
J. Balnis (2021)
Glutaminolysis-induced mTORC1 activation drives non-alcoholic steatohepatitis progression.
N. Cabré (2021)
iTRAQ-based quantitative proteomics suggests mitophagy involvement after Rice black-streaked dwarf virus acquisition in insect vector small brown planthopper Laodelphax striatellus Fallén.
Haoqiu Liu (2021)
Melatonin and its mechanism of action in the female reproductive system and related malignancies.
M. Ezzati (2021)
NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF‐1α signaling in hepatocellular carcinoma
B. Sun (2021)
Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration.
S. Ranganayaki (2021)
Caffeic Acid Phenethyl Ester Protects Kidney Mitochondria against Ischemia/Reperfusion Induced Injury in an In Vivo Rat Model
Justina Kamarauskaitė (2021)
Mitochondrial bioenergetic pathways in blood leukocyte transcriptome decrease after intensive weight loss but are rescued following weight regain in female physique athletes
H. V. Sarin (2021)
Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health
Jessica C. Ezeji (2021)
Isobaric tags for relative and absolute quantitation-based proteomics analysis of the effect of ginger oil on bisphenol A-induced breast cancer cell proliferation
Dan Lei (2021)
Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses
Inseo Choi (2021)
Metabolic Regulation of Hypoxia-Inducible Factors in Hypothalamus
Dan Du (2021)
Generation of Reactive Oxygen Species by Mitochondria
P. Hernansanz-Agustín (2021)
Reactive Oxygen Species: A Promising Therapeutic Target for SDHx-Mutated Pheochromocytoma and Paraganglioma
Katerina Hadrava Vanova (2021)
Loss of SDHB Promotes Dysregulated Iron Homeostasis, Oxidative Stress, and Sensitivity to Ascorbate
Judith Goncalves (2021)
iPSC-Derived Hereditary Breast Cancer Model Reveals the BRCA1-Deleted Tumor Niche as a New Culprit in Disease Progression
L. Portier (2021)
Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes
Christian A. Lee (2020)
Redox Signaling from Mitochondria: Signal Propagation and Its Targets
P. Ježek (2020)
Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid
Y. Liu (2020)
Iron: An Essential Element of Cancer Metabolism
Myriam Y. Hsu (2020)
Mitochondrial Redox Hubs as Promising Targets for Anticancer Therapy
L. Ippolito (2020)
Riding the tiger – physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix
M. Brand (2020)
Human 2-oxoglutarate-dependent oxygenases: nutrient sensors, stress responders, and disease mediators
Sally C. Fletcher (2020)
Hysteresis and bistability in the succinate-CoQ reductase activity and reactive oxygen species production in the mitochondrial respiratory complex II
N. I. Markevich (2020)
Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma
Y. Liu (2020)
The iron-sulfur protein subunit of succinate dehydrogenase is critical in driving mitochondrial reactive oxygen species generation in Apostichopus japonicus.
Lianlian Sun (2020)
NRF2 in human neoplasm: Cancer biology and potential therapeutic target.
Yang Liu (2020)
Metabolic Pathways of Eukaryotes and Connection to Cell Mechanics
C. Mierke (2020)
ROS-associated immune response and metabolism: a mechanistic approach with implication of various diseases
Sharmistha Banerjee (2020)
Mitochondrial complex II and reactive oxygen species in disease and therapy
Katerina Hadrava Vanova (2020)See more